While mergers and acquisitions, and attendant financings may not be at a blistering pace globally, the prognosis for deal activity in the healthcare sector remains healthy, in particular as the consolidation of providers, the vertical integration of healthcare services and acquisitions and investments in the life sciences and medtech sectors continue. Therefore, in this report we focus on recent developments that stand to impact healthcare financings.